Non-Small Cell Lung Cancer Resources
Navigating Care Library Resources
The Navigating Care Library
includes articles about cancer, chemotherapy regimens and drugs from the
the National Cancer Institute and other experts.
Non-Small Cell Lung Cancer Articles
- General Information About Non-Small Cell Lung Cancer
- Stages of Non-Small Cell Lung Cancer
- Treatment Option Overview
- Treatment of Occult Non-Small Cell Lung Cancer
- Treatment of Stage 0 (Carcinoma in Situ)
- Treatment of Stage I Non-Small Cell Lung Cancer
- Treatment of Stage II Non-Small Cell Lung Cancer
- Treatment of Stage IIIA Non-Small Cell Lung Cancer
- Treatment of Stage IIIB and Stage IIIC Non-Small Cell Lung Cancer
- Treatment of Newly Diagnosed Stage IV, Relapsed, and Recurrent Non-Small Cell Lung Cancer
- Treatment of Progressive Stage IV, Relapsed, and Recurrent Non-Small Cell Lung Cancer
- To Learn More About Non-Small Cell Lung Cancer
-
Non-Small Cell Lung Cancer Chemotherapy Treatments
- Alimta chemotherapy
- Cisplatin + Alimta chemotherapy
- Cisplatin + Gemzar chemotherapy
- Cisplatin + Gemzar + Avastin chemotherapy
- Cisplatin + Navelbine chemotherapy
- Cisplatin + Taxol chemotherapy
- EP chemotherapy
- Gemzar + Alimta chemotherapy
- Gemzar + Navelbine chemotherapy
- Gemzar + Taxol chemotherapy
- Parapatin + Gemzar chemotherapy
- Parapatin + Navelbine chemotherapy
- Parapatin + Taxotere chemotherapy
- Paraplatin + Taxol + Avastin chemotherapy
- Taxol chemotherapy
- Taxol + Navelbine chemotherapy
- Taxol + Paraplatin chemotherapy
- Taxotere chemotherapy
- Taxotere + cisplatin chemotherapy
- Taxotere + Gemzar chemotherapy
-
Non-Small Cell Lung Cancer Chemo and Biologic Drugs
- Abraxane (paclitaxel (with albumin) injection)
- Alecensa (alectinib)
- Alimta (pemetrexed)
- Alunbrig (brigatinib)
- Exkivity (mobocertinib)
- Gavreto (pralsetinib)
- Gemzar (gemcitabine)
- Gilotrif (afatinib)
- Imjudo (tremelimumab-actl injection)
- Iressa (gefitinib)
- Lorbrena (lorlatinib)
- Lumakras (sotorasib)
- Navelbine (vinorelbine)
- Opdivo (nivolumab injection)
- Portrazza (necitumumab injection)
- Retevmo (selpercatinib)
- Rozlytrek (entrectinib)
- Rybrevant (amivantamab-vmjw injection)
- Tabrecta (capmatinib)
- Tagrisso (osimertinib)
- Tarceva (erlotinib)
- Tecentriq (atezolizumab injection)
- Tepmetko (tepotinib)
- Velban (vinblastine)
- Vizimpro (dacomitinib)
- Xalkori (crizotinib)
- Zykadia (ceritinib)
- more Non-Small Cell Lung Cancer articles...
This information is not intended to replace the advice of a doctor. Navigating Care disclaims any liability for the decisions you make based on this information. This information was sourced and adapted from the National Cancer Institute's web site, www.cancer.gov.